A Novel Influenza A Virus Activating Enzymefrom Porcine Lung: Purification andCharacterization
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 37887439X | ||
| 003 | CHVBK | ||
| 005 | 20180305123417.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 161128e20030220xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1515/BC.2003.024 |2 doi |
| 035 | |a (NATIONALLICENCE)gruyter-10.1515/BC.2003.024 | ||
| 245 | 0 | 2 | |a A Novel Influenza A Virus Activating Enzymefrom Porcine Lung: Purification andCharacterization |h [Elektronische Daten] |c [M. Sato, S. Yoshida, K. Iida, T. Tomozawa, H. Kido, M. Yamashita] |
| 520 | 3 | |a Proteolytic activation of hemagglutinin, an envelope glycoprotein of the influenza virus, by host proteases is essential for infection and proliferation of the virus. However, there is no well-defined, inherent source of host proteases in man or swine, both of which are natural hosts for human influenza viruses. We have recently isolated a 32 kDa protein in a high salt extract from porcine lungs, which possess the hemagglutinin processing activity. In this study, we attempted to purify another hemagglutinin processing enzyme from porcine lung. The purified enzyme, named tryptase TC30, exhibited a molecular mass of about 30 kDa by SDS-PAGE and 28.5 kDa by gel filtration chromatography, suggesting that it is a monomer. Tryptase TC30 cleaved peptide substrates with Arg at the P1 position, and preferentially substrates with the Ser-Ile-Gln-Ser-Arg sequence corresponding to the HA cleavage site sequence of the A/PR/8/34 influenza virus. Among various inhibitors tested, trypsintype serine protease inhibitors, such as aprotinin, antipain, benzamidine and leupeptin, efficiently inhibited the proteolytic activity of the enzyme. The N-terminal 40 amino acid sequence of tryptase TC30 exhibits more than 60% homology to mast cell tryptases from mice MCP-6 and human tryptase-α and -β. These data indicate that tryptase TC30, the 30 kDa enzyme from porcine lung, is a novel hemagglutinin-cleaving enzyme. | |
| 540 | |a Copyright © 2003 by Walter de Gruyter GmbH & Co. KG | ||
| 690 | 7 | |a Biochemistry |2 nationallicence | |
| 690 | 7 | |a Molecular biology |2 nationallicence | |
| 690 | 7 | |a Cellular biology |2 nationallicence | |
| 700 | 1 | |a Sato |D M. |4 aut | |
| 700 | 1 | |a Yoshida |D S. |4 aut | |
| 700 | 1 | |a Iida |D K. |4 aut | |
| 700 | 1 | |a Tomozawa |D T. |4 aut | |
| 700 | 1 | |a Kido |D H. |4 aut | |
| 700 | 1 | |a Yamashita |D M. |4 aut | |
| 773 | 0 | |t Biological Chemistry |d Walter de Gruyter |g 384/2(2003-02-20), 219-227 |x 1431-6730 |q 384:2<219 |1 2003 |2 384 |o bchm | |
| 856 | 4 | 0 | |u https://doi.org/10.1515/BC.2003.024 |q text/html |z Onlinezugriff via DOI |
| 908 | |D 1 |a research article |2 jats | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1515/BC.2003.024 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Sato |D M. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Yoshida |D S. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Iida |D K. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Tomozawa |D T. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Kido |D H. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Yamashita |D M. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Biological Chemistry |d Walter de Gruyter |g 384/2(2003-02-20), 219-227 |x 1431-6730 |q 384:2<219 |1 2003 |2 384 |o bchm | ||
| 900 | 7 | |b CC0 |u http://creativecommons.org/publicdomain/zero/1.0 |2 nationallicence | |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-gruyter | ||